These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36462469)

  • 1. Brief international cognitive assessment for MS (BICAMS) and global brain volumes in early stages of MS - A longitudinal correlation study.
    Skorve E; Lundervold AJ; Torkildsen Ø; Riemer F; Grüner R; Myhr KM
    Mult Scler Relat Disord; 2023 Jan; 69():104398. PubMed ID: 36462469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS.
    Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
    Mult Scler Relat Disord; 2020 Nov; 46():102577. PubMed ID: 33296975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition in multiple sclerosis: Between cognitive reserve and brain volume.
    Fenu G; Lorefice L; Arru M; Sechi V; Loi L; Contu F; Cabras F; Coghe G; Frau J; Fronza M; Sbrescia G; Lai V; Boi M; Mallus S; Murru S; Porcu A; Barracciu MA; Marrosu MG; Cocco E
    J Neurol Sci; 2018 Mar; 386():19-22. PubMed ID: 29406960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
    Mult Scler Relat Disord; 2019 Nov; 36():101408. PubMed ID: 31610403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls.
    Frau J; Fenu G; Signori A; Coghe G; Lorefice L; Barracciu MA; Sechi V; Cabras F; Badas M; Marrosu MG; Cocco E
    BMC Neurol; 2018 May; 18(1):67. PubMed ID: 29751782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stages of brain volume loss and performance in the Brief International Cognitive Assessment for Multiple Sclerosis.
    Miyazaki Y; Niino M; Takahashi E; Nomura T; Naganuma R; Amino I; Akimoto S; Minami N; Kikuchi S
    Mult Scler Relat Disord; 2022 Nov; 67():104183. PubMed ID: 36116381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.
    Sandi D; Rudisch T; Füvesi J; Fricska-Nagy Z; Huszka H; Biernacki T; Langdon DW; Langane É; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2015 Nov; 4(6):499-504. PubMed ID: 26590654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue.
    Betscher E; Guenter W; Langdon DW; Bonek R
    Neurol Neurochir Pol; 2021; 55(1):59-66. PubMed ID: 33047783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis.
    Motyl J; Friedova L; Ganapathy Subramanian R; Vaneckova M; Fuchs TA; Krasensky J; Blahova Dusankova J; Kubala Havrdova E; Horakova D; Uher T
    Acta Neurol Belg; 2024 Feb; 124(1):109-118. PubMed ID: 37552396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values.
    Darwish H; Zeinoun P; Farran N; Ghusn H; Yamout B; Khoury SJ
    J Int Neuropsychol Soc; 2022 Jan; 28(1):94-103. PubMed ID: 33563350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.
    Uher T; Vaneckova M; Sormani MP; Krasensky J; Sobisek L; Dusankova JB; Seidl Z; Havrdova E; Kalincik T; Benedict RH; Horakova D
    Eur J Neurol; 2017 Feb; 24(2):292-301. PubMed ID: 27873386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief International Cognitive Assessment for Multiple Sclerosis scores are associated with the cortical thickness of specific cortical areas in relapsing-remitting patients.
    Davion JB; Lopes R; Jougleux C; Viard R; Dumont J; Leclerc X; Outteryck O
    Rev Neurol (Paris); 2022 Apr; 178(4):326-336. PubMed ID: 34657733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tunisian version of the brief international cognitive assessment for multiple sclerosis: Validation and normative values.
    Souissi A; Mrabet S; Ferchichi W; Gharbi A; Nasri A; Djebara MB; Kacem I; Gouider R
    Mult Scler Relat Disord; 2022 Feb; 58():103444. PubMed ID: 34929452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
    Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
    Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.